AR and prostate carcinoma: These data provide the first confirmation of the connection between CDK5 and AR in prostate cancer cells and prostate carcinoma specimens [40], suggesting that phosphorylation of AR by direct interaction with CDK5 protects AR protein against degradation by the ubiquitin–proteasome mechanism.